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Abstract
The clonal dissemination of VanB-type vancomycin-resistant Enterococcus faecium (VREfm) strains in three Swedish hospitals
between 2007 and 2011 prompted further analysis to reveal the possible origin and molecular characteristics of the
outbreak strain. A representative subset of VREfm isolates (n = 18) and vancomycin-susceptible E. faecium (VSEfm, n = 2)
reflecting the spread in time and location was approached by an array of methods including: selective whole genome
sequencing (WGS; n = 3), multi locus sequence typing (MLST), antimicrobial susceptibility testing, virulence gene profiling,
identification of mobile genetic elements conferring glycopeptide resistance and their ability to support glycopeptide
resistance transfer. In addition, a single VREfm strain with an unrelated PFGE pattern collected prior to the outbreak was
examined by WGS. MLST revealed a predominance of ST192, belonging to a hospital adapted high-risk lineage harbouring
several known virulence determinants (n$10). The VREfm outbreak strain was resistant to ampicillin, gentamicin,
ciprofloxacin and vancomycin, and susceptible to teicoplanin. Consistently, a vanB2-subtype as part of Tn1549/Tn5382 with
a unique genetic signature was identified in the VREfm outbreak strains. Moreover, Southern blot hybridisation analyses of
PFGE separated S1 nuclease-restricted total DNAs and filter mating experiments showed that vanB2-Tn1549/Tn5382 was
located in a 70-kb sized rep17/pRUM plasmid readily transferable between E. faecium. This plasmid contained an axe-txe toxin-
antitoxin module associated with stable maintenance. The two clonally related VSEfm harboured a 40 kb rep17/pRUM plasmid
absent of the 30 kb vanB2-Tn1549/Tn5382 gene complex. Otherwise, these two isolates were similar to the VREfm outbreak
strain in virulence- and resistance profile. In conclusion, our observations support that the origin of the multicentre outbreak
was caused by an introduction of vanB2-Tn1549/Tn5382 into a rep17/pRUM plasmid harboured in a pre-existing high-risk E.
faecium ST192 clone. The subsequent dissemination of VREfm to other centres was primarily caused by clonal spread rather
than plasmid transfer to pre-existing high-risk clones.
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Introduction
Enterococci, and Enterococcus faecium in particular, have
undergone a transition from harmless gut commensals to be a
leading cause of multidrug resistant hospital infections [1]. E.
faecium is associated with urinary tract infections, endocarditis,
infections in indwelling catheters and septicaemia in hospitalised
patients [2,3]. Notably, a pronounced increase in bacteraemias
caused by E. faecium in Europe has been reported [4]. The ability
of hospital adapted lineages of E. faecium to compile antibiotic
resistance and virulence factors by horizontal gene transfer might
be attributable to this observation [1].
The use of Multi Locus Sequence Typing (MLST) has been
considered a standard method for global epidemiological surveil-
lance [5], while pulsed-field gel electrophoresis (PFGE) is the
preferred method for examination of E. faecium seen in local
outbreaks. The clonal complex (CC) 17 has shown to pool hospital
associated E. faecium strains characterised by a high rate of
recombination, multidrug resistance as well as numerous virulence
determinants [6–8]. Newer insights pertained with another type of
population structure analysis, Bayesian Analysis of Population
Structure (BAPS) of CC17 strains, show divergent origins of
sequence type (ST) lineages within CC17. CC17 strains could
largely be divided in two BAPS groups, 2-1 (lineage 78), and 3-3
(lineages 17 and 18), with the corresponding MLST ancestry
nodes in parenthesis [9].
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e103274
A worldwide increased prevalence of acquired resistance to
commonly used antibiotics is observed in clinical isolates of E.
faecium. A total of eight gene clusters, vanA,B,D,E,G,L,M,N,
have been associated with acquired vancomycin resistance in
enterococci (VRE) [10–13]. VanA VRE is most prevalent globally,
but VanB-type VRE are predominant in Australia and on the rise
in many European countries [14–19]. The vanB gene cluster
include three subtypes, vanB1-3, conferring inducible low- to
high-level resistance to vancomycin and susceptibility to teicopla-
nin [20]. The predominant subtype vanB2 is an integral part of an
Integrative Conjugative Element transposon family Tn1549/
Tn5382 supporting transfer of vanB2 [21]. Several plasmid
replicon types encoding glycopeptide resistance as well as
stabilising toxin-antitoxin systems have been linked to CC17
strains [22]. Moreover, a number of putative virulence genes have
been associated with E. faecium and it is hypothesised that their
phenotypes might work in concert to promote host colonisation
and subsequent invasion [2].
The prevalence of vancomycin resistant E. faecium (VREfm) in
Sweden remained low until 2007 when a large hospital associated
outbreak occurred [15]. Three hospitals in separate counties were
involved. The outbreak was not declared over until 2011.
The aim of the present study was to explore the origin of the
outbreak strain by performing molecular characterisation of
representative isolates of the outbreak strain and compare them




All cases of vancomycin-resistant enterococci (VRE) are
mandatorily reported to the Public Health Agency of Sweden
and collected for resistance and epidemiological typing. In 2007,
an increasing number of notified VRE-cases were seen in
Stockholm County, related to a clonal VanB-type E. faecium
strain. The strain was subsequently reported in two other
geographically distant counties (Västmanland and Halland) [15].
During the autumn 2008, clonally related isolates of VanB-type
Efm (n = 17) from separate infection/colonisation events in these
three counties were selected for molecular studies. The selected
isolates occurred early and late during the outbreak period and
represented isolates with divergent resistance profiles and related
PFGE subtypes. Four blood isolates from Collection B (see below)
were also included in the molecular analyses, yielding a total of 21
isolates in Collection A.
In an attempt to reveal the origin of the E. faecium vanB
outbreak strain, all consecutive E. faecium blood culture isolates
from 1st of January 2006 to 31st of August 2009 (n = 191;
Collection B) diagnosed at the Karolinska University Hospital
Huddinge where the outbreak was first identified, were collected
and analysed by PFGE; 2006 (n = 45), 2007 (n = 32), 2008 (n = 71)
and 2009 (n = 43). Four of these isolates were selected for further
analysis using whole genome sequencing (WGS) with the Roche
454 pyrosequencing platform. The selection criterion was based
on PFGE patterns, where the first vancomycin susceptible
(VSE1036), the first vancomycin resistant (VRE1044) and the
most recent vancomycin resistant (VRE1261) isolate with indis-
tinguishable or closely related PFGE-patterns to the outbreak
strain, were chosen. For comparison, one vancomycin resistant
isolate (VRE0576) from 2006 was chosen because of its divergent
PFGE pattern. E. faecium 64/3 [23], BM4105RF and BM4105-
Str [24] were used as recipients in filter mating experiments.
Isolates from a polyclonal cluster of vanB2 positive E. faecium
from 2002–2004 in the Swedish county Örebro [18] were included
in the ICESluvan Q8 PCR to evaluate their vanB transposon
signature.
Antimicrobial susceptibility testing
The minimum inhibitory concentration (MIC) was determined
using Etest (BioMerieux) and interpreted according to the clinical
breakpoints of the European committee on Antimicrobial Suscep-
tibility Testing (EUCAST) (www.eucast.org). For ciprofloxacin, a
tentative breakpoint was used classifying isolates with MIC .
32 mg/L as high level resistant [25].
PFGE and MLST
For SmaI-digestion, the protocol adapted by Saeedi et al. [26]
was used with 5 U/mL lysozyme added in the lysis buffer. The
bands were separated with the following program: Block I switch
time 3 to 26,5s for 14 hours and 50 minutes. Block II: switch time
0,5 to 8,5s for 6 hours and 25 minutes. Total run time 21 hours
and 15 minutes at 6V with 120u. The PFGE patterns were
analysed and compared using BioNumerics software (version 6.6,
Applied Maths). The Dice coefficient was used for pair-wise
comparison of patterns, and the un-weighted pair group method
with arithmetic mean (UPGMA) for pattern grouping. Isolates
clustering above 97% were considered identical and isolates with
identity .90% closely related.
MLST was performed using the method adapted by Homan et
al. [5] with the following primers: adk1n, adk2n, atp1n, atp2n,
ddl1, ddl2, gdh1, gdh2, gyd1, gyd2, pstS1n, pstS2n, purK1n and
purK2n.
Detection of genes by PCR and isolation of bacterial DNA
Extraction of DNA for all PCRs were performed by BioRobot
M48 (Qiagen), according to the manufacturers manual. Primers
and positive controls are described in Table S1.
The chosen virulence genes are associated with high-risk
genotypes, and included esp [27], hyl [28], acm [29], efaAfm
[30], sgrA, ecbA, scm, orf903/2010/2514 and pilA/B [31–33].
PCRs genotyping presence of vanB [20] and linkage to Tn5382
[34] was done. PCRs were conducted as stated in Table S1. PCR
was performed using the JumpStart REDTaq Readymix PCR
Reaction mix (Sigma), with a standard program of 1 min in 95uC
followed by 30 cycles at 95uC for 30 sec, 30 sec of annealing in the
temperature given in Table S1, 72uC for 1 min with a final
elongation step at 72uC for 7 min. The presence of vanB in
transconjugants was tested by PCR using 1 ml of bacterial culture
in BHI broth and an additional initial denaturation step of 10 min
at 95uC.
Southern blotting and hybridisation
PFGE analysis of S1-digested DNA was used to analyse the
plasmid content. Plugs were made as for SmaI digestion, and the
digestion was performed as described by Rosvoll et al. [22]. The
Vacugene XL system (Amersham Biosciences) was used for
Southern blotting. Consecutive hybridisation was performed using
rep17/pRUM, vanB and axe-txe probes in the mentioned order.
Characterisation of the reppLG1 [35] and rep2/pRE25 [36] plasmid
determinants were also done by Southern blotting and hybridisa-
tion after S1-nucelase PFGE. Probes were made by amplification
using positive controls (see Table S1), and labelled using the PCR
DIG synthesis kit (Boehringer Mannheim). The same hybridisa-
tion protocol as in Rosvoll et al. [22] was used with the following
modification: The DNA was purified after the first PCR using the
Cycle Pure Kit (zDNA).
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Conjugative transfer of vanB
Filter mating was performed according to Bjørkeng et al. [18]
with some minor modifications, using the E. faecium 64/3 and E.
faecium BM4105-RF as recipient strains for the first filter mating,
and BM4015-Str in retransfer. Briefly, the isolates were grown
together on MF-Millipore membrane filters for 24 h, spotted on
selective BHI agar plates containing either vancomycin (8 mg/L),
fusidic acid (10 mg/L) and rifampicin (20 mg/L), or all three
antibiotics together. The bacterial suspension was serially diluted
down to 1029 and incubated at 37uC for 48 h. In the retransfer
experiments, the recipients were selected on plates containing
1000 mg/L streptomycin.
Whole genome sequencing and analysis
Chromosomal DNA from the four isolates (VSE1036,
VRE1044, VRE1261 and VRE0576) was prepared using the
DNeasy Blood and Tissue Kit (Qiagen) with lysozyme (20 mg/
mL) added to the lysis buffer and further treated with RNase. The
protocol also allowed purification of plasmids. Libraries were
prepared and used for whole genome shotgun sequencing on a 4-
region picotiter plate with the Roche 454 FLX system according to
standard protocols (www.454.com). Raw sequencing data were
processed with standard filters using the GS Run Processor (v 2.6),
generating between 246084 and 310421 reads for each of the
strains with average lengths between approximately 307 and 320
nucleotides, corresponding to between 78750175 and 99124035
nucleotides. Reads were assembled de novo with the accompany-
ing GS de novo assembler software (v 2.6) (454 Newbler algorithm)
generating between 201 and 302 contigs with a length of more
than 100 nucleotides. The GS Reference mapper software (v 2.6)
was subsequently used for homology comparisons between the
different strains and to find homologies to specific query gene
sequences and also used to identify indels and point mutations that
separated the different strains. Some small plasmids could be
identified by screening for contigs where individual reads mapped
to both ends of the contig. The contigs were tentatively linked to
each other by comparison of molecular biology data, identification
of individual reads mapping to two different contigs and
comparisons with published genomes. The tentative gene content
of the contigs was automatically analysed at NCBI with the
Prokaryotic Genome Annotation Pipeline (PGAP).
In Figure S1 alignment of genome sequences against the
reference genome of Aus0004 (NC_017022) was done by
reordering the contigs of VRE1044 against the Aus0004 reference
genome using Mauve 2.3.1. The reordered contigs of VRE1044
were then used as reference to reorder the contigs of the other
isolates before the genomes were aligned using progressiveMauve
[37].
The Whole Genome Shotgun projects have been deposited at
DDBJ/EMBL/GenBank under the accessions JAAJ00000000
(VSE1036), JAAK00000000 (VRE0576), JAAL00000000
(VRE1044) and JAAM00000000 (VRE1261). The versions
described in this paper are versions JAAJ01000000,
JAAK01000000, JAAL01000000 and JAAM01000000.
Results
PFGE patterns and antimicrobial susceptibility of VREfm
and VSEfm
In an attempt to identify a putative ancestor of the VREfm
outbreak strain, we examined consecutive blood isolates (n = 191,
Collection B) of E. faecium from Karolinska University Hospital,
Huddinge, during a four-year period (2006–2009) covering the
time of appearance of the presumably first clinical isolate of the
outbreak VREfm strain. A dominant PFGE pattern (n = 37; 26
VSEfm and 11 VREfm) was indistinguishable or closely related to
that of the VREfm outbreak strain (named SE-EfmB-0701).
Representative isolates with this PFGE-pattern are shown in
Figure 1. Among the blood isolates analysed in retrospect, this
PFGE pattern was observed for the first time in a vancomycin
susceptible isolate (VSEfm) from February 2007 and soon after in
two more VSEfm. Three additional VREfm with identical PFGE
pattern were detected during the autumn of 2007. The first known
clinical isolate (VRE0651) was found in an abdominal infection in
August 2007. In 2008 another eight VREfm and 14 VSEfm
isolates with the same PFGE pattern were detected. During
January 1st until August 31st 2009 no more VREfm but still 10
VSEfm of the SE-EfmB-0701 PFGE type were detected.
Antimicrobial susceptibility testing of the 37 blood culture
isolates revealed high-level gentamicin resistance (n = 14; 38%) as
well as ampicillin (100%) and ciprofloxacin (100%) resistance and
teicoplanin susceptibility (100%). The vanB gene was detected in
all VREfm isolates.
In collection A (n = 21), representing PFGE patterns as diverse
as possible at the time of selection (autumn 2008), a total of 9
subgroups (a to i) of the pattern SE-EfmB-0701 were found
(Table 1). All PFGE patterns displayed a similarity .90%, thereby
fulfilling the suggested definition of relatedness (.81%) according
to Morrison et al. [38]. The isolates did however not group
together consistently in relation to their geographical origin
(Figure 1).
The nineteen VREfm isolates in collection A had vancomycin
MICs ranging from 8 to $256 mg/L and were susceptible to
teicoplanin, consistent with the vanB2 genotype. All the isolates
were resistant to ampicillin and ciprofloxacin, and seven displayed
high-level resistance to gentamicin. The two VSE-isolates
(VSE1036 and VSE1027) in collection A were susceptible to both
vancomycin and teicoplanin, but expressed resistance to ampicillin
and ciprofloxacin (Table 1).
MLST and WGS analyses of VREfm and VSEfm
Collection A (n = 21) were studied in greater detail by MLST
and PCR for virulence genes (Table 1). Three isolates of the
outbreak strain and one unrelated VREfm isolate were examined
by WGS; VSE1036 (ST192), VRE1044 (ST192), VRE1261
(ST192) and VRE0576 (ST17). In collection A, all isolates
including the two VSE belonged to ST192 except one single
locus (VRE0673, ST78) and two double locus (VRE0881 and
VRE0576, ST17) variants of ST192. All isolates except VRE0881
and VRE0576 belonged to the ST78 lineage. All isolates except
VRE0576, a pre-outbreak vanB-positive ST17 isolate from 2006
had a related PFGE pattern as shown by SmaI PFGE (Figure 1).
The MLST- and PFGE results concurred moderately in showing
relation, since the isolates with the most divergent PFGE patterns
(VRE0673, VRE0776 and VRE0881) in two of three cases had
deviating MLST profiles.
The WGSs from the outbreak isolates VRE1044, VRE1261,
and VSE1036 as well as the unrelated vanB-positive pre-outbreak
isolate VRE0576 were aligned against the chromosome of an E.
faecium isolate from Australia which contains a vanB2 transposon
(Aus0004) (Figure S1, vanB2 transposons are indicated by red
triangles). The WGS of the three ST192 outbreak isolates were
naturally more homologous and shared several regions (highlight-
ed by black triangles) that were not present in the genome
sequences of either VRE0576 or Aus0004 (both ST17) although it
should be noted that the plasmid sequences of Aus0004 were not
included in this comparison. The VRE0576 and Aus0004
genomes showed many unique regions (white areas). Furthermore,
Outbreak of VanB-Type Enterococcus faecium ST192
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VRE1044 and VRE1261 showed some unique regions (green
triangles) that were not present in VSE1036. Further analyses of
these regions suggested they belong to mobile genetic ele-
ments.VRE1044 and VRE1261 showed only minor differences.
Antimicrobial resistance determinants and virulence
genes of VREfm and VSEfm
All VREfm isolates in collection A harboured the vanB2 gene
as an integral part of Tn1549/Tn5382 demonstrated by the
vanXB-ORFC-PCR (Table 1). This link was also confirmed by
WGSs in three VREfm isolates (Table S2). WGS data of VRE576
revealed the same genetic organisation of the vanB2 transposon as
well as 99% nucleotide (nt) identity to Tn1549. Interestingly,
WGS data from VRE1044 and VRE1261 showed the same
vanB2 transposon organisation and 99% nucleotide identity to
Tn1549, but also an additional 2588 bp inserted between nt 5014
and 5015 of Tn1549. We performed ICESluvan Q8 PCR (Table
S1) covering the putative insertion region in the remaining VRE
isolates to disclose a potential unique insertion signature of the
vanB transposon in SE-EfmB-0701 isolates. Presence of an
approximately 2.6 kb insertion was confirmed in the vanB
transposon of all the VREfm SE-EfmB-0701 isolates in collection
A. The 2588 bp insert sequence is 89% identical to the region in
Clostridium saccharolyticum-like K10 (GenBank Acc.
No. FP929037) encoding a retron-type reverse transcriptase. In
line with this, the 2588 bp sequence encodes a putative protein of
610 amino acids (aa) with 99% identity to a putative reverse
transcriptase/maturase from Faecalibacterium prausnitzii A2-165
(GenBank Acc. No. EEU96266) and a putative group II intron-
encoded protein LtrA (reverse transcriptase and RNA maturase)
from Flavonifractor plautii ATCC 29863 (GenBank Acc.
No. EHM54980). The putative protein further shows 43%
identity to the group II intron 599 aa multifunctional protein
LtrA in Lactococcus lactis (GenBank Acc. No. U50902). LtrA is
known to have reverse transcriptase, RNA maturase and site-
specific DNA endonuclease activity mediating intron splicing and
mobility [39].
The gyrA and parC genes extracted from the WGSs revealed
SNPs associated with ciprofloxacin resistance. Two mutation
events in each gene were found (Table 1), and both aa
combinations (GyrA Arg83, ParC Ile80 or GyrA Ile83, ParC
Arg80) have been described previously in E. faecium isolates with
ciprofloxacin MICs $16 mg/L [25,40,41]. Moreover, the tetra-
cycline resistance determinant tetM and the macrolide resistance
determinant ermB were also found in three and four WGS isolates,
respectively (Table S2).
All isolates of the PFGE type SE-EfmB-0701 harboured esp,
sgrA, acm, scm, pilB, efaAfm, orf2010 and orf 2514. Moreover, 17
of 20 isolates contained hyl. PCR data showed that the genes pilA,
ecbA and orf903 occurred in six, one and one of 20 isolates,
respectively. The ecbA and orf903 genes were found in isolates
with unique PFGE subtypes in this collection (VRE0776 and
VRE0673) (Table 1). WGS data revealed that pilA (VRE1044 and
VRE1261) and ecbA (VSE1036, VRE1044 and VRE1261) were
present with a nucleotide match of 1672/1976 (85%) for pilA and
2766/3173 (87%) for ecbA compared to reference sequences in
Figure 1. Dendrogram of Sma I PFGE of the 21 isolates in collection A. The dendogram shows that 20 of the isolates are clonal (lane 1–20)
and one is divergent (lane 21). The symbol ¤ in the dendrogram indicates a similarity of 90.6%. The PFGE-type nomenclature is based on the
following: SE stands for Sweden, EfmB stands for E. faecium with vanB, the number 07 represents year 2007 (the year the index was identified) and the
last number is a serial number. The letter at the end describes which PFGE-subtype the isolate belongs to.
doi:10.1371/journal.pone.0103274.g001
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isolates E1162 and TX16, respectively. In addition, VSE1036,
VRE1044, and VRE1261 carried a truncated version of pilA
(219 bp) 100% identical to the reference sequences. Blastn search
of the pilA and ecbA sequences within the NCBI shotgun sequence
database revealed that these two genes had a notable SNP
variation between different strains (0–20%). The original pilA and
ecbA primers used yielded no good matches in the WGS sequences
which explain why we got few positive PCR products with these
primers. All our collection A isolates were positive for these genes
using new primers (pilA 2 and ecbA 2 Table S1) targeting
conserved regions in the WGS and reference ecbA and pilA genes.
Plasmid localisation of Tn1549-type transposon
By BLAST alignment of the contigs from VRE1044 and
VRE1261 containing the vanB2 transposon against the WGS data
of the VSE1036 isolate, the exact AT-rich location of the vanB2
transposon insertion site could be identified in contig00062 of
VSE1036 (Figure 2 and blue triangle in Figure S1). The
transposon insertion site was identical for VRE1044 and
VRE1261 and corresponded with 100% identity to sequence in
contig00062 of VSE1036 (Figure 2).
To get a better picture of the plasmid content we performed
Southern blot hybridisation of S1 nuclease treated total DNAs
separated by PFGE using specific replication (rep) gene probes
(Table 1). WGS data gave additional information on plasmid
sequences as well as resistance genes and Tn1549/Tn5382 (Table
S2). Replication genes of rep-classes rep2/pRE25, rep11/pB82, rep17/
pRUM and reppLG1 were present in all four WGS, with some
nucleotide differences in the pre-outbreak isolate (VRE0576)
compared to the other three isolates. VRE0576 also differed from
the other isolates by lacking a rep14/pRI1-class gene present with
identical nucleotide identity scores in the other WGSs, and by
containing a putative repunique/pCIZ2-class gene absent in the other
WGSs. Notably, VRE1044 and VRE1261 contained two rep2/
pRE25-sequences with SNP differences on different contigs,
consistent with the observed two rep2/pRE25 plasmids in the
hybridisation analyses (Table 1 and S2). The VSE1036 isolate had
a similar hybridisation pattern as VRE1044 and VRE1261, but
did only have one 50-kb plasmid and one contig with rep2/pRE25.
Hybridisation results showed that all VREfm isolates harboured
the vanB resistance gene on an approximately 70-kb rep17/pRUM
replicon (shown for representative isolates VRE0726, VRE0734
and VRE0881 in Figure 3 lanes 5, 8 and 11, and VRE0690,
VRE0653, VRE0776 in Figure 4 lanes 5, 7 and 9). Further
hybridisation of selected isolates revealed a dominant common
plasmid content pattern for VRE0726, VRE0651, VRE0678,
VRE1044, VRE1261, and VRE0650, and some minor differences
in the other 11 characterised isolates (Table 1).
Interestingly, the two VSE isolates clonally related to the
VREfm outbreak strain (VSE1027 and VSE1036) differed from
the common pattern by having a rep17/pRUM replicon 30 kb
smaller than that of the VREfm isolates (Table 1), corresponding
to the size of the vanB2-Tn1549/Tn5382 transposon. Notably,
the pRUM repA was found with 100% homology to the reference
sequence in VRE0576 (GenBank Accession number
JAAK00000000), and present with 97% homology in VSE1036
(JAAJ00000000), VRE1044 (JAAL00000000) and VRE1261
(JAAM00000000). A subsequent comparison of the rep17/pRUM
replicon sequence in the three latter strains showed 100%
homology. Thus, these plasmids share identical signature sequenc-
es for pRUM repA as well as for the Tn1549/Tn5382 transposon
insertion site.
Tn1549/Tn5382-related genes, axe-txe and the vanB2 gene
were found within the same contig in the VRE1044 and VRE1261
isolates, thus supporting the S1 nuclease PFGE hybridisation and
PCR data showing linkage of vanB2-Tn1549/Tn5382 and axe-
txe genes on the same replicon (representative isolates in Figure 3
lanes 5, 8 and 11). WGS analyses of VSE1036 showed that the
sequence corresponding to the transposon insertion site of
VRE1044 and VRE1261 (Figure 2) mapped to the same
contig00062 as axe-txe (Table S2) typically found on rep17/pRUM
replicons. Interestingly, the reference pRUM plasmid contains a
putative relaxase gene and a mobilisation gene both consistently
absent from all four WGSs.
Transferability studies of the VanB determinant
All but 2 (VRE0651 and VRE0673) out of 10 tested VREfm
isolates produced transconjugants with a low frequency of 1028 to
10211 per donor, close to the detection limit, using E. faecium 64/
3 as a recipient (Table 2). Transconjugants were confirmed by
PFGE using SmaI-digestion (Figure S2 and S3). E. faecium
recipient BM4105-RF did not support conjugation within the
detection limit.
S1 nuclease PFGE and subsequent hybridisation of the 64/3
transconjugants revealed that all the transconjugants contained a
vanB-rep17/pRUM plasmid of variable size (110–170 kb), larger
than the original 70-kb donor plasmids (Figures 3, 4, S5 and S6).
With the exception of VRE0690664/3 (170 kb) (Figure 4 lane 4
and Figure S5 lane 7) and VRE0776664/3 (110 kb) (Figure 4
lane 8 and Figure S5 lane 9), the transconjugants had a vanB-
rep17/pRUM-rep2/pRE25 containing plasmid of about 140 kb
(Figure 3 lanes 6, 9 and 12, Figure 4 lane 6, Figure S5 lanes 3,
5 and 11 and Figure S6 lanes 5, 8 and 11) which corresponds to
the joint size of the 70-kb rep2/pRE25 and the 70-kb vanB-rep17/
pRUM of their donors. Conversely, the two donors VRE0690 and
VRE0776 that gave transconjugants with different sized plasmids
both lacked a copy of the 70-kb rep2/pRE25 plasmid (Table 1).
VRE0776 contain a 40-kb rep2/pRE25 plasmid which joint with the
70-kb vanB-rep17/pRUM could result in the 110-kb vanB-rep17/
pRUM-rep2/pRE25 seen in Figure S5 lane 9. In VRE0690 the
170 kb plasmid of the transconjugant did not hybridise to rep2/
pRE25 suggesting that the 170-kb plasmid result from joining of the
Figure 2. Sequence comparison of the insertion regions of Tn1549/5382. The figure shows the transposon insertion regions of VRE0576
versus VRE1044 and VRE1261 and the corresponding region in VSE1036 (contig00062). Tn1549/Tn5382 left and right end imperfect inverted repeats
are shown in bold capital letters. Vertical lines indicate identical nucleotides.
doi:10.1371/journal.pone.0103274.g002
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70-kb vanB-rep17/pRUM with the 100-kb unknown replicon
(Figure S5 lane 7).
The transconjugants were tested for susceptibility to streptomy-
cin in order to identify eligible donors for retransfer experiments.
The first generation transconjugants originating from donors
VRE0726 (ST192), VRE0734 (ST192) and VRE0881 (ST17)
were susceptible. The streptomycin resistance in the other
transconjugants probably originate from co-transfer of streptomy-
cin resistance with the plasmids of their clinical isolate donors
Figure 3. S1-nuclease PFGE and corresponding Southern hybridisations with rep17/pRUM, vanB and axe-txe probes. These results
illustrated transfer from donors VRE0726, VRE0734 and VRE0881 (lanes 5, 8 and 11) of a similar sized plasmid (approximately 140 kb) to 64/3 (lane 1)
(1st generation transconjugants shown in lanes 6, 9 and 12) which was subsequently retransferred to BM4105Str (lane 2) (2nd generation
transconjugants shown in lanes 7, 10 and 13) when using the 1st generation transconjugants as donors. Lane 3 vanB positive control V583, lane 4
rep17/pRUM, axe-txe and vanB positive control E. faecium U37, lanes M low-range PFGE marker.
doi:10.1371/journal.pone.0103274.g003
Figure 4. S1-nuclease PFGE and corresponding Southern hybridisations with vanB and rep17/pRUM probes. Donors VRE0690, VRE0653
and VRE0776 (lanes 5, 7 and 9) and their respective transconjugants (lanes 4, 6 and 8) illustrate transfer of different sized plasmids co-hybridising to
vanB and rep17/pRUM (circa 110–150 kb) into 64/3 (lane 1). Lane 2 vanB positive control V583, lane 3 rep17/pRUM and vanB positive control E. faecium
U37, lane M low-range PFGE marker.
doi:10.1371/journal.pone.0103274.g004
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(VRE0653, VRE0683, VRE0690, VRE0688 and VRE0776) that
all showed high-level resistance to streptomycin.
Retransfer and following S1 nuclease PFGE and Southern
hybridisations demonstrated that the vanB-rep17/pRUM-rep2/pRE25
140-kb hybrid plasmids (Figure 3 and Figure S6) were stable in
size and readily transferable with transfer rates of 1023–1025
transconjugants per donor (Table 2). Transconjugants were
confirmed by PFGE using SmaI-digestion (Figure S4).
Discussion
A total of 872 VREfm cases were notified during the outbreak
in 2007 to 2011, predominantly as faecal colonisation in elderly
hospitalised patients with underlying diseases. Less than 10% of
the VREfm isolates were recorded from blood, urine or wound
samples [15].
Molecular characterisation of a representative subset of related
outbreak isolates showed a strong predominance of ST192, which
is a single-locus variant of ST78 and considered to be a high-risk
genotype [42]. The MLST- and PFGE results were moderately
congruent, as the isolates with less similar PFGE patterns and
virulence profiles (VRE0673, VRE0776 and VRE0881) in two of
three cases had a divergent MLST profile. Previous BAPS data
have concluded that the ST78 and ST17 lineages are located in
BAPS group 2-1 and 3-3, respectively, and not closely related.
This contrasts our PFGE results which grouped VRE0881 (ST17
lineage) in the SE-EfmB-0701 PFGE type (ST78 lineage). This
observation as well as the carriage of a unique virulence gene by
VRE0673 (orf903) and VRE0776 (only ecbA gene detected by the
original PCR primers), could be explained by the lean inclusion
criteria of relatedness by PFGE, thereby accepting not genetically
related pulsotypes as related. The long collection time (around a
year) and evidence of increased DNA banding pattern polymor-
phism by E. faecium compared to other bacteria [38] was used as
basis for our choice of inclusion criteria. However, the unique
vanB transposon signature found in all the SE-EfmB-0701 isolates
links VRE0881, VRE0776 and VRE0673 to the outbreak.
The examined isolates expressed multidrug-resistance and
harboured several specific genes associated with increased
virulence. The vancomycin susceptible isolates (VSE1027 and
VSE1036) from the start of the outbreak period were clonally
related and exerted the same co-resistance- and virulence profile as
the VREfm isolates (Figure 1 and Table 1). Moreover, plasmid
profiling and WGS data (Table 1 and S2, Figure S1) also indicated
close relatedness between SE-EfmB-0701 PFGE type isolates with
minor differences in plasmid profile as well as clear differences in
gene content compared to the pre-outbreak isolate.
Our results support the notion that internalisation of the vanB
transposon into the rep17/pRUM plasmid coincide with the
successful spread of this high-risk strain. The rep17/pRUM replicon
has previously been shown to harbour a segregation stability
module encoded by a toxin-antitoxin cassette (axe-txe) which have
been shown to support maintenance of linked antimicrobial
resistance genes [43]. Notably, rep17/pRUM replicons with the axe-
txe cassette have been shown to be present in a majority of CC17-
like strains [22]. WGS analyses revealed that the SE-EfmB-0701
pRUM replicons contained an axe-txe module with a 100%
identity to the original pRUM axe-txe sequence.
A rep17/pRUM-vanB2-Tn1549/Tn5382-axe-txe-plasmid of ap-
proximately 120–130 kb has previously been described in a
polyclonal cluster of E. faecium from 2002–2004 in the Swedish
county Örebro. This cluster originated from BAPS-group 3-3
(ST17, ST18 and single locus variants of these) [18]. The Örebro
isolates displayed a different PFGE pattern from SE-EfmB-0701
[15] and had a vanB2 transposon without the unique signature
found in SE-EfmB-0701.
The repeatedly observed fusion between the vanB2-containg
rep17/pRUM plasmids and rep2/pRE25 replicons during conjugation
experiments is an interesting feature. The WGS data did not
support the presence of the putative relaxase and mobilisation
protein associated with the reference pRUM plasmid. This could
explain the need for the vanB2-containing rep17/pRUM plasmids to
fuse with a conjugation system from other intracellular sources in
Table 2. Transfer frequencies between donors and recipients after filter mating.
Primary matings Transfer frequency
Donor (PFGE
subtype) (ST) Recipient Transconjugants/donor Transconjugants/recipient
VRE0653 (a) (192) 64/3 661029 4610210
VRE0651 (b) (192) 64/3 ,661029a ,261029
VRE0683 (c) (192) 64/3 861029 5610211
VRE0734 (c) (192) 64/3 2610211 2610212
VRE0726 (d) (192) 64/3 161029 3610211
VRE0690 (e) (192) 64/3 261029 1610210
VRE0688 (f) (192) 64/3 761029 661029
VRE0673 (g) (78) 64/3 ,261028a ,161029
VRE0776 (h) (192) 64/3 1610210 561028
VRE0881 (i) (17) 64/3 261028 7610211
Secondary matings
VRE0726664/3 BM4105-Str 761025 261023
VRE0734664/3 BM4105-Str 161023 261023
VRE0881664/3 BM4105-Str 361024 161023
aIsolates VRE0651 and VRE0673 did not support conjugation within given detection limits.
doi:10.1371/journal.pone.0103274.t002
Outbreak of VanB-Type Enterococcus faecium ST192
PLOS ONE | www.plosone.org 8 August 2014 | Volume 9 | Issue 8 | e103274
order to be mobilised. Several studies have described mosaicism
and/or recombination events between enterococcal plasmids
[22,44] which may support enhanced host range or other
functional benefits associated with several replicons in one
plasmid.
There is a noteworthy reservoir of vanB in intestinal anaerobes,
and introduction of vanB2-Tn1549/Tn5382 in enterococci from
other co-habitants (mainly Gram-positive anaerobes) in the
intestinal environment has been experimentally observed [45].
Howden et al. [46] tested the ecological impact by phylogenetic
analysis of the transposons and their insertion sites, and showed
that a diversification was likely due to a higher grade of de novo
VRE generation compared to cross-transmission between entero-
coccal strains than previously believed. They also observed an
increasing incidence of nosocomial VRE infections despite
engagement of control interventions to limit transmission between
patients. Based on the extensive PFGE and selective MLST
analyses in this study, it is highly probable that the closely related
VSEfm ST192 strain was a successful hospital coloniser in Sweden
already in 2007. Acquisition of the vanB2 transposon by the
VSEfm ST192 outbreak strain is the most likely hypothesis on how
vancomycin resistance appeared in this strain. The WGS data
strongly support that a vanB2 transposon with unique signature
was inserted within a rep17/pRUM-plasmid with an unique pRUM
repA sequence signature in a strain already present, causing a
parallel evolution between VSEfm clones without, and VREfm
clones with the rep17/pRUM-vanB2-Tn1549/Tn5382-axe-txe ar-
rangement.
Suggested clearance time for VRE faecal colonisation is
estimated to be 4 years [47], but others have suggested that
environmentally adapted VRE are capable of inhabiting the
intestines in small numbers for even longer [48,49].
The selective enriched broth used in some laboratories in
Sweden before January 2009 with a vancomycin concentration of
32 mg/L was not suitable for vanB-type resistance screening. To
address this problem, microbiological laboratories were then
advised to reduce the concentration to 4 mg/L [15]. However,
vanB-type VRE may have even lower MICs [17,50]. Importantly,
the EUCAST disk diffusion test used by most laboratories in
Sweden as the phenotypic vancomycin-susceptibility test method
rely on observing the zone edge quality for identification of low
level vanB-type resistance. This introduces observer experience as
a variable [51].
In conclusion, the molecular analyses revealed that the E.
faecium outbreak strain belonged to the high-risk genetic lineage
of ST192. The strain was resistant to several commonly used
antibiotics and harboured several virulence genes. A successful
rep17/pRUM-plasmid containing a vanB transposon with a unique
genetic signature originating from other intestinal bacterial species
was present in all the VREfm isolates related to the outbreak
strain. The rep17/pRUM plasmid harboured a toxin-antitoxin
module supporting plasmid maintenance. In addition the rep17/
pRUM replicon can easily join with conjugative genetic elements
supporting spread to other high-risk E. faecium clones. The
current phenotypic screening methods might hamper efforts in
limiting VREfm spread, as low-MIC vanB-type VRE might go
undetected [51].
Supporting Information
Figure S1 Alignment of genome sequences from VRE1044 (row
2), VRE1261 (row 3), VSE1036 (row 4) and VRE0576 (row 5)
against the reference genome Aus0004 NC_017022 (row 1). The
similarity plot indicates average similarity for each region.
Coloured blocks indicate regions of sequence homology in the
genomes and white areas indicate regions with low sequence
homology. Red triangles indicate contigs containing Tn1549/
Tn5382 (VRE1044 contigs 00036 and 00041, VRE1261 contigs
00049 and 00044/VRE0576 contig 00004). The blue triangle
indicates the transposon Tn1549/Tn5382 insertion region in
contig 00062 of VSE1036. This contig also contains the axe-txe
genes typically found on rep17/pRUM replicons. Black (VRE1044,
VRE1261 and VSE1036) and green (VRE1044 and VRE1261)
triangles highlight regions with contigs or partial contigs found in
the outbreak isolates but not in VRE576 or Aus0004.
(PDF)
Figure S2 SmaI PFGE of first generation transconjugants (TC)
(lanes 5, 7, 9, 11) showing divergent band patterns compared with
the clinical isolate donors (lanes 6, 8, 10 and 12) and similar
pattern with recipient 64/3 (lane 2). Lanes 1 and 13 low-range
PFGE marker, lane 3 vanB positive control E. faecalis V583, lane
4 rep17/pRUM positive control E. faecium U37, lanes 5 and 6 TC
and donor VRE0726, lanes 7 and 8 TC and donor VRE0734,
lanes 9 and 10 TC and donor VRE0683, lanes 11 and 12 TC and
donor VRE0688.
(PDF)
Figure S3 SmaI PFGE of first generation transconjugants (TC)
(lanes 5, 7, 9, 11) showing divergent band patterns compared with
the clinical isolate donors (lanes 6, 8, 10 and 12) and similar
pattern with recipient 64/3 (lane 2). Lanes 1 and 13 low-range
PFGE marker, lane 3 vanB positive control E. faecalis V583, lane
4 rep17/pRUM positive control E. faecium U37, lanes 5 and 6 TC
and donor VRE0690, lanes 7 and 8 TC and donor VRE0653,
lanes 9 and 10 TC and donor VRE0776, lanes 11 and 12 TC and
donor VRE0881.
(PDF)
Figure S4 SmaI PFGE of second generation transconjugants
(TCs) (lanes 6–8, 11–13 and 15–17) showing divergent band
patterns compared with the first generation transconjugant donors
(lanes 5, 10 and 14) and similar pattern with recipient BM4105-Str
(lane 4). Lanes 1, 9 and 18 low-range PFGE marker, lane 2 vanB
positive control E. faecalis V583, lane 3 rep17/pRUM positive
control E. faecium U37, lane 5 donor VRE0726664/3, lanes 6–8
TCs VRE0726664/3xBM4105-Str, lane 10 donor
VRE0734664/3, lanes 11–13 TCs VRE0734664/3xBM4105-
Str, lane 14 donor VRE0881664/3, lanes 15–17 TCs
VRE0881664/3xBM4105-Str.
(PDF)
Figure S5 S1-nuclease PFGE and corresponding Southern
hybridisations with rep2/pRE25 and rep17/pRUM probes showing
co-hybridisation in first generation transconjugants (lanes 3, 5, 9
and 11). Lanes 1 and 12 low-range PFGE marker, lanes 2 and 3
donor and TC VRE0683, lanes 4 and 5 donor and TC VRE0688,
lanes 6 and 7 donor and TC VRE0690, lanes 8 and 9 donor and
TC VRE0776, lanes 10 and 11 donor and TC VRE0653.
(PDF)
Figure S6 S1-nuclease PFGE and corresponding Southern
hybridisations with rep2/pRE25 and rep17/pRUM probes showing
co-hybridisation in first (lane 5, 8 and 11) and second generation
transconjugants (lane 6, 9 and 12). Lane M low-range PFGE
marker, lane 1 rep17/pRUM and rep2/pRE25 positive control E.
faecium U37, lane 2 recipient 64/3, lane 3 VRE1044, lane 4
VRE0726, lane 5 VRE0726664/3, lane 6 VRE0726664/
3xBM4105-Str, lane 7 VRE0734, lane 8 VRE0734664/3, lane
9 VRE0734664/3xBM4105-Str, lane 10 VRE0881, lane 11
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VRE0881664/3, lane 12 VRE0881664/3xBM4105-Str, lane 13
recipient BM4105-Str.
(PDF)
Table S1 Primers used in this article.
(PDF)
Table S2 Plasmid replication, resistance, toxin-antitoxin system
and conjugative transposon genes found in the WGSs of the pre-
outbreak isolate VRE576 and the three outbreak isolates
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acm TGACGAGCGGTGATAAAACAGCTA 636 53 TUH7-15 [1] [2] 
 ATAGGCTGTTCATCTGCTCGTCTTA     
efaAfm  GTTCGATAACTTGATGGAAAC 561 53 TUH7-15 [3] 
 CATCTGATAGTAAGAATCTCCTTG     
esp  AGATTTCATCTTTGATTCTTGG 510 55 TUH7-15 [4] 
 AATTGATTCTTTAGCATCTGG     
hyl GTTAGAAGAAGTCTGGAAACCG Ca 500 53 TUH7-15 [5] 
 TGCTAAGATATTCCTCTACTCG     
srgA (orf2351) AATGAACGGGCAAATGAG 671 50 TUH7-15 [6] 
 CTTTTGTTCCTTAGTTGGTATGA     
ecbA (orf2430) GCAGTTTACAATGGTGTGAAGCAA 963 55 TUH7-15 [6] 
 CGGCTAATGAGTATTTGTCGTTCC     
ecbA 2 GGTTGGACTGTCTTTGCGAATGGC 951 54 VRE1044 This study 
 TGGCCGATTTACAATGAGTTCACTC     
scm (orf418) CTAACTGGTAACTATGGCTTGT 1109 55 TX16 [7] [6] 
 GTCCGTGCTGTCACTTGT     
pilA (orf1904) AGGCAGATTATGGTGATGTT 619 55 TX16 [6] 
 GGCTGTTGGTTCTTTATCTG     
pilA 2 TGGTTGATCGGCAAATGTAA 211 54 VRE1044 This study 
 AGCAGATTATGGGGACGTTG     
pilB (orf2569) GTGTTTGCAGAGGAGACAGC 1121 55 TX16 [6] 
 GACAGAATAATTTACTGGGTCG     
orf903 (fms11) TCAACGGACATACCATACCA 409 55 TX16 [6] 
 CTTACCATCAACGATCTGCC     
orf2010 (fms14) GTAGCGAAGAAAATGAGATGG 1021 55 TX16 [6] 
 TAACTTGACTGAATCGGTGC     
orf2514 (fms15) AGTTCCAGTTGCGAGTCAGA 989 55 TX16 [6] 
 ATGTAGTCGGATTCGGTGC     
vanB consensus CAAAGCTCCGCAGCTTGCATG 484 58 C68  [1] 
 TGCATCCAAGCACCCGATATAC     
vanXB-ORFC ATCAAGGACTCAACCGTAATT 873 60 C68 [8] 
 TGAGTTGTGGAAGTCGATTAGAG     
axe-txe CTTTAATGGCTCAGGTTTTCCTAA 
ATGAGGATGCTGAAACACTTATT 
351 55 U37 [9] 
     
rep17/pRUM TACTAACTGTTGGTAATTCGTTAAAT 604 52 U37 [10] [11] 
 ATCAAGGACTCAACCGTAATT     
reppLG1 TTTAAGGCGGATAGAGTTTACAACG 
CTGATAGGCTTTTAACAGTGTCGTGT 
864 56 TX16  [12] 
     
rep2/pRE25 GAGAACCATCAAGGCGAAAT 
ACCAGAATAAGCACTACGTACAATCT 
630 56 RE25 [13] [11] 
     
ICESluvan Q8 CAAGTGGTAACGCAGGATGA 
AAAGATAGCCGTCTGCGTGT 
2512/5100 55 5-F9 [14] 
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Table S2. Plasmid replication, resistance, toxin-antitoxin system and conjugative transposon 
genes found in the WGSs of the pre-outbreak isolate VRE576 and the three outbreak isolates 























VSE1036 contig00084 100.00 1434 
VRE1044 contig00079 100.00 1434 
contig00081 89,76 1358 
VRE1261 contig00085 100.00 1434 
contig00098 89,76 1358 
repA pB82  11 






VSE1036 contig00090 100.00 579 
VRE1044 contig00087 100.00 579 












VSE1036 contig00113 83.50 976 
VRE1044 contig00109 83.50 976 











VSE1036 contig00075 97.32 1043 
VRE1044 contig00070 97.32 1043 












VSE1036 contig00071 99.7 1041 
VRE1044 contig00086 99.7 1041 













VSE1036       
VRE1044       













VSE1036       
VRE1044 contig00036 99,71 1029 
VRE1261 contig00049 99,71 1029 
erythromycin resistance 
transferase 






VSE1036 contig00100 99.46 738 
VRE1044 contig00095 99.46 738 
VRE1261 contig00106 99.46 738 
Tetracycline resistance 
(tetM) Tn916 




VSE1036 contig00094 94,62 1357 
VRE1044 contig00089 94,62 1356 
VRE1261 contig00096 94,62 1357 
TA-system 
genes 
Antitoxin of axe-axe 
pRUM 






VSE1036 contig00062 100.00 270 
VRE1044 contig00036 100.00 270 
VRE1261 contig00049 100.00 270 
Toxin of axe-txe pRUM 






VSE1036 contig00062 100.00 258 
VRE1044 contig00036 100.00 258 











VSE1036       
VRE1044 contig00036 99,92 1194 
VRE1261 contig00049 99,92 1194 
Excisionase Tn1549 






VSE1036       
VRE1044 contig00036 99 201 




Figure S1. Alignment of genome sequences from VRE1044 (row 2), VRE1261 (row 3), VSE1036 (row 4) and VRE0576 (row 5) against the reference genome 
Aus0004 NC_017022 (row 1). The similarity plot indicates average similarity for each region. Coloured blocks indicate regions of sequence homology in the genomes and 
white areas indicate regions with low sequence homology. Red triangles indicate contigs containing Tn1549/Tn5382 (VRE1044 contigs 00036 and 00041, VRE1261 
contigs 00049 and 00044/VRE0576 contig 00004). The blue triangle indicates the transposon Tn1549/Tn5382 insertion region in contig 00062 of VSE1036. This contig 
also contains the axe-txe genes typically found on rep17/pRUM replicons. Black (VRE1044, VRE1261 and VSE1036) and green (VRE1044 and VRE1261) triangles highlight 
regions with contigs or partial contigs found in the outbreak isolates but not in VRE576 or Aus0004.  
Figure S2. SmaI PFGE of first generation transconjugants (TC) (lanes 5, 7, 9, 11) showing divergent 
band patterns compared with the clinical isolate donors (lanes 6, 8, 10 and 12) and similar pattern 
with recipient 64/3 (lane 2). Lanes 1 and 13 low-range PFGE marker, lane 3 vanB positive control E. 
faecalis V583, lane 4 rep17/pRUM positive control E. faecium U37, lanes 5 and 6 TC and donor VRE0726, 
lanes 7 and 8 TC and donor VRE0734, lanes 9 and 10 TC and donor VRE0683, lanes 11 and 12 TC and 







Figure S3. SmaI PFGE of first generation transconjugants (TC) (lanes 5, 7, 9, 11) showing 
divergent band patterns compared with the clinical isolate donors (lanes 6, 8, 10 and 12) and 
similar pattern with recipient 64/3 (lane 2). Lanes 1 and 13 low-range PFGE marker, lane 3 vanB 
positive control E. faecalis V583, lane 4 rep17/pRUM positive control E. faecium U37, lanes 5 and 6 TC 
and donor VRE0690, lanes 7 and 8 TC and donor VRE0653, lanes 9 and 10 TC and donor VRE0776, 







Figure S4.  SmaI PFGE of second generation transconjugants (TCs) (lanes 6-8, 11-13 and 15-17) showing divergent 
band patterns compared with the first generation transconjugant donors (lanes 5, 10 and 14) and similar pattern with 
recipient BM4105-Str (lane 4). Lanes 1, 9 and 18 low-range PFGE marker, lane 2 vanB positive control E. faecalis V583, 
lane 3 rep17/pRUM positive control E. faecium U37, lane 5 donor VRE0726x64/3, lanes 6-8 TCs VRE0726x64/3xBM4105-Str, 
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Figure S5. S1-nuclease PFGE and corresponding Southern hybridisations with rep2/pRE25 and rep17/pRUM probes showing co-
hybridisation in first generation transconjugants (lanes 3, 5, 9 and 11). Lanes 1 and 12 low-range PFGE marker, lanes 2 and 3 
donor and TC VRE0683, lanes 4 and 5 donor and TC VRE0688, lanes 6 and 7 donor and TC VRE0690, lanes 8 and 9 donor and 
TC VRE0776, lanes 10 and 11 donor and TC VRE0653.  
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kb 









Figure S6. S1-nuclease PFGE and corresponding Southern hybridisations with rep2/pRE25 and rep17/pRUM probes showing co-hybridisation 
in first (lane 5, 8 and 11) and second generation transconjugants (lane 6, 9 and 12).  Lane M low-range PFGE marker, lane 1 rep17/pRUM and 
rep2/pRE25 positive control E. faecium U37, lane 2 recipient 64/3, lane 3 VRE1044, lane 4 VRE0726, lane 5  VRE0726x64/3, lane 6 
VRE0726x64/3xBM4105-Str, lane 7 VRE0734, lane 8 VRE0734x64/3, lane 9 VRE0734x64/3xBM4105-Str, lane 10 VRE0881, lane 11 
VRE0881x64/3, lane 12 VRE0881x64/3xBM4105-Str, lane 13 recipient BM4105-Str. 
rep2/pRE25 hybridisation rep17/pRUM hybridisation S1 nuclease PFGE 
